Search - tctmd.com

Displaying 181 - 200 of 4576

Sort: Relevancy | Date

Presentation TCT 2016

The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials

Presenter: Donald Cutlip, Christian Hengstenberg, David E. Kandzari

October 31, 2016

Presentation TCT 2016

Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent

Presenter: Donald Cutlip, Christian Hengstenberg, Sigmund Silber

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, David G. Rizik

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

Presentation TCT 2016

Case Presentation: Evaluation and Management of Recurrent DES Restenosis

Presenter: Fernando Alfonso, Stephan Windecker, Adnan K. Chhatriwalla

October 30, 2016

Presentation TCT 2016

Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis?

Presenter: Fernando Alfonso, Stephan Windecker, Ron Waksman

October 30, 2016

Presentation TCT 2016

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Brian K. Whisenant

October 30, 2016

Presentation TCT 2016

Prognosis and Treatment Options for DES Restenosis and Re-restenosis

Presenter: Fernando Alfonso, Stephan Windecker

October 30, 2016

Presentation TCT 2016

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First!

Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Freek W.A. Verheugt

October 30, 2016

Presentation TCT 2016

Left Main Stenting: Fascinating Cases and Lessons From the EXCEL Angiographic Core Lab

Presenter: David E. Kandzari, Jens Flensted Lassen, Philippe Généreux

October 30, 2016

News Conference News TCT 2016

BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year

TCT Daily Staff

October 30, 2016

Presentation TCT 2016

Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis

Presenter: Fernando Alfonso, Stephan Windecker, Ehrin J. Armstrong

October 30, 2016

Presentation TCT 2016

How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond

Presenter: Fernando Alfonso, Stephan Windecker, Giulio G. Stefanini

October 30, 2016

Presentation TCT 2016

Case #3 (From Taiwan): A Case of an Unexpanded Stent With Rotablator Burr Stall: How Did I Treat?

Presenter: Jun-Jack Cheng, Yoshito Yamamoto, Wen-Lieng Lee

October 30, 2016

Presentation TCT 2016

Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and Thrombosis Timing

Presenter: Fernando Alfonso, Stephan Windecker, Robert-Jan van Geuns

October 30, 2016

Presentation TCT 2016

Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety?

Presenter: Fernando Alfonso, Stephan Windecker, Giulio Guagliumi

October 30, 2016

Presentation TCT 2016

Case #3 (From Taiwan): A Case of an Unexpanded Stent With Rotablator Burr Stall: Case Introduction

Presenter: Jun-Jack Cheng, Yoshito Yamamoto, Wen-Lieng Lee

October 30, 2016

Presentation TCT 2016

OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications

Presenter: Fernando Alfonso, Stephan Windecker, Stephen WL Lee

October 30, 2016

Presentation TCT 2016

Complex Left Main Cases With Planned Two-stent Approach

Presenter: David E. Kandzari, Jens Flensted Lassen, David G. Rizik

October 30, 2016

Presentation TCT 2016

Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis?

Presenter: Fernando Alfonso, Stephan Windecker, Gary S. Mintz

October 30, 2016

Advertisement

The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials

Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Case Presentation: Evaluation and Management of Recurrent DES Restenosis

Is Brachytherapy the Best Last Hope for Recurrent DES Restenosis?

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes!

Prognosis and Treatment Options for DES Restenosis and Re-restenosis

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First!

Left Main Stenting: Fascinating Cases and Lessons From the EXCEL Angiographic Core Lab

BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year

Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis

How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond

Case #3 (From Taiwan): A Case of an Unexpanded Stent With Rotablator Burr Stall: How Did I Treat?

Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and Thrombosis Timing

Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety?

Case #3 (From Taiwan): A Case of an Unexpanded Stent With Rotablator Burr Stall: Case Introduction

OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications

Complex Left Main Cases With Planned Two-stent Approach

Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content